Trial intelligence / Profile preview

Dronedarone versus amiodarone for maintenance of sinus rhythm in atrial fibrillation

NL-OMON31364Phase 3Not yet recruiting

Sponsor
Sanofi
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Dronedarone arm with Amiodarone arm (2 arms). Primary endpoint: Treatment failure. Planned start Jul 2007; status: not yet recruiting.

02

Drugs

dronedaroneamiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NL-OMON31364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call